Backgroup/relevance: Overweight and obesity, defined by a respective body mass index of above 25 and 30 kg/m2, are getting increasingly common in all regions of the world. Obesity is currently estimated to be present in more than 10% of the global population while overweight roughly reached an estimate of 40% in 2016. Overweight dramatically increases the risk for a wide range of disorders such as diabetes mellitus and other metabolic and cardiovascular disorders subsumed under the term metabolic syndrome, increasing the risk for life-threatening cardiovascular events such as myocardial infarction and stroke. Similar to other chronic diseases such as mental health disorders, prescribing medication was oftentimes insufficient and should be complemented by patient empowerment to reach sufficient treatment adherence and control of lifestyle factors. Thereby, overweight and obesity can easily be challenged by patients themselves without pharmacological intervention. Overweight may place central in the crossroad between metabolic and mental health for several reasons. Excessive body fat is known to cause subclinical inflammation that was also associated with many psychiatric disorders such as major depression. Similarly, the hypothalamic-pituitary-adrenal axis relevant for stress response was shown to be dysregulated in both metabolic and mental health disorders. Study design: In this study, non-pharmacological interventions are applied in healthy women with overweight or obesity and self-perceived psychological stress. Women staying at the "la pura" women´s health resort (www.lapura.at/) are invited to partake in the study and receive a short-term intervention of calory restriction. Thereby, either F.X. Mayr or very-low-calory-diet (VLCD) will be applied, reducing calory intake to 700-800 kcal/die. Following random assigment to four treatment arms, half of the women also receive a 7-session clinical-psychological intervention consisting of biofeedback, individualized psycho-education on stress prevention and mindlessness training. Women are assessed at baseline and after two weeks of interventions for metabolic parameters such as insulin functioning, anthropometric parameters such as body weight and body fat, blood parameters such as sex hormones, fat metabolism and liver function, parameters of neuroplasticity such as brain derived neurotrophic factor (BDNF), as well as psychological and biological stress correlates and mental health symptom dimensions.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
44
VLCD restricts calory intake to 630 - 700 kcal per day (20% fat, 34% protein, 46% carbohydrates). F.X. Mayr diet similarly applies calorie restriction to 700 - 800 kcal per day and includes daily ingestion of isotonic magnesium sulfate solution.
Three sessions of biofeedback (50 minutes) over a time frame of 14 days, aimed at improving biological functions and especially heart-rate-variability under stress condition.
VAMED Gender Insitute
Gars am Kamp, Lower Austria, Austria
PSS score
Perceived Stress Scale total score
Time frame: Baseline, changes over two weeks
BODI
buron-out-diagnostic-inventory scores, 4 summary items and 3 stress self-ratings
Time frame: Baseline, changes over two weeks
BSI
Brief Symptom Inventory, 9 dimensional subscores and global severity score
Time frame: Baseline, changes over two weeks
waist-to-height ratio
Anthropometric parameter
Time frame: Baseline
HbA1c
Glycated hemoglobin
Time frame: Baseline
HOMA-IR
Functional parameter for insulin resistance
Time frame: Baseline
Matsuda Index
Functional parameter for insulin sensitivity
Time frame: Baseline
Body mass index
weight in relation to height
Time frame: Baseline, changes over two weeks
HRV
heart rate variability
Time frame: Baseline, changes over two weeks
Body fat
measured by bioimpedance analysis
Time frame: Baseline, changes over two weeks
lean mass
measured by bioimpedance analysis
Time frame: Baseline, changes over two weeks
Phase angle
ratio of reactance versus electric resistance, measured by bioimpedance analysis
Time frame: Baseline, changes over two weeks
Resistin
Adipocines
Time frame: Baseline, changes over two weeks
Leptin
Adipocines
Time frame: Baseline, changes over two weeks
Secretagogin
Adipocines
Time frame: Baseline, changes over two weeks
Adiponectin
Adipocines
Time frame: Baseline, changes over two weeks
BDNF
brain derived neurotrophic factor
Time frame: Baseline, changes over two weeks
Estrogen
Sex hormone
Time frame: Baseline, changes over two weeks
Testosterone
Sex hormone
Time frame: Baseline, changes over two weeks
Luteinizing hormone
Sex hormone
Time frame: Baseline, changes over two weeks
Follicle-stimulating hormone
Sex hormone
Time frame: Baseline, changes over two weeks
Total cholesterol
Lipid metabolism
Time frame: Baseline, changes over two weeks
High-density lipoprotein (HDL)
Lipid metabolism
Time frame: Baseline, changes over two weeks
BSRI
Bem sex role inventory, female, male, neutral scores
Time frame: Baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.